dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Hemolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| David-Cu, R; Findlay, RD; Taeusch, HW; Walther, FJ | 1 |
1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Hemolysis
| Article | Year |
|---|---|
Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants.
Topics: Animals; Biological Products; Drug Combinations; Epithelial Cells; Epithelium; Fatty Alcohols; Hemolysis; Hemorrhage; Humans; In Vitro Techniques; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Models, Biological; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants; Rats | 1995 |